BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7116758)

  • 1. Treatment of severe hypertension with intravenous labetalol.
    Papademetriou V; Notargiacomo AV; Khatri IM; Freis ED
    Clin Pharmacol Ther; 1982 Oct; 32(4):431-5. PubMed ID: 7116758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
    Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
    Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.
    Smith WB; Clifton GG; O'Neill WM; Wallin JD
    Hypertension; 1983; 5(4):579-83. PubMed ID: 6862581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
    Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
    Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol in resistant hypertension.
    Hedstrand H
    Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of intravenous labetalol for the treatment of hypertensive urgency.
    Huey J; Thomas JP; Hendricks DR; Wehmeyer AE; Johns LJ; MacCosbe PE
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):284S-289S. PubMed ID: 3415804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I.v. labetalol in the treatment of hypertension following coronary-artery surgery.
    Morel DR; Forster A; Suter PM
    Br J Anaesth; 1982 Nov; 54(11):1191-6. PubMed ID: 7138722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labetalol infusion in hypertensive emergencies.
    Lebel M; Langlois S; Belleau LJ; Grose JH
    Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol in severe and resistant hypertension.
    Williams LC; Murphy MJ; Parsons V
    Br J Clin Pharmacol; 1979; 8(Suppl 2):143S-147S. PubMed ID: 526395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
    Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK; Thomas GW; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1979 Nov; 2(9):499-500. PubMed ID: 522807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
    Rumboldt Z; Bagatin J; Vidovic A
    Int J Clin Pharmacol Res; 1983; 3(1):47-54. PubMed ID: 6679507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol in essential hypertension.
    Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
    J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.